See the DrugPatentWatch profile for vascepa

Based on the information provided, I was unable to find specific details regarding an income-based patient assistance program for Vascepa. However, I did find some information that may be helpful for those seeking financial assistance for this medication.

Vascepa, a prescription medication used to lower triglyceride levels, is manufactured by Amarin Pharma, Inc. According to Amarin's Patient Assistance Program page [1], they offer the Amarin Cares program, which provides Vascepa at no cost to eligible patients who lack prescription drug coverage and meet certain income requirements. The program is designed to help patients who are uninsured, underinsured, or have limited financial resources.

It is important to note that the Amarin Cares program does not explicitly state that it is an income-based patient assistance program for Vascepa. However, it does mention that eligibility is based on a variety of factors, including income. To determine if you qualify for the program, you will need to apply directly through Amarin's patient assistance website [1].

For more information on patient assistance programs and drug pricing, you can also consult resources such as DrugPatentWatch.com [2]. This website provides comprehensive data on drug patents, pricing, and related financial assistance programs.

In summary, while there is no explicit confirmation of an income-based patient assistance program for Vascepa, Amarin Pharma, Inc. does offer the Amarin Cares program, which may help eligible patients with financial assistance for Vascepa.

Sources:
[1] Amarin Pharma, Inc. (n.d.). Amarin Cares. Retrieved from https://www.amarincares.com/
[2] DrugPatentWatch.com. (n.d.). Vascepa. Retrieved from https://www.drugpatentwatch.com/drugs/vascepa/